Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|December 5, 2017
Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical dataYassine Lalami, Jean Klastersky
Current Opinion in Oncology|February 19, 2011
Recurrent thyroid cancer: a molecular-based therapeutic breakthroughYassine Lalami, Ahmad Awada
Current Opinion in Oncology|June 17, 2020
Use of granulocyte-colony stimulating factors in older patients: a review of recently published dataJean A Klastersky, Lissandra Dal Lago, Yassine Lalami
World Journal of Clinical Cases|June 1, 2017
Unusual presentation of nasopharyngeal carcinoma with rectal metastasisMalvine Vogel, Hampig Raphael Kourie, Martine Piccart, et al.
Drugs & Aging|August 7, 2009
Management of head and neck cancer in elderly patientsYassine Lalami, Gilberto de Castro, Chantal Bernard-Marty, et al.
Current Opinion in Oncology|March 23, 2006
Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumorsYassine Lalami, Pierre Vereecken, Didier Dequanter, et al.
Head & Neck|October 22, 2014
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancerYassine Lalami, Camillo Garcia, Patrick Flamen, et al.
Frontiers in Oncology|February 12, 2026
Long-term outcomes and patient profiles following intensity-modulated radio-chemotherapy for nasopharyngeal cancer in a nonendemic regionTatiana Dragan, Ibrahim Chiairi, Maurine Salmon, et al.
Head & Neck|November 15, 2005
Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluationPhillipe Lothaire, Evandro de Azambuja, Didier Dequanter, et al.
Acta Oto-Laryngologica|October 20, 2006
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?Didier Dequanter, Philippe Lothaire, Ahmad Awada, et al.
Pageof 2